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In their recent paper [1] Good and Hermsmeier discuss
the effects of test set selection on the evaluation and com-
parison of SAR methodologies. In particular they examine
the impact that analogue effect has on overestimating the
predictivness of drug vs non-drug models built by
Bayeisan modeling. The analogue effect is a result of most
drug and druglike compendia having extensive sets of
analogues. When selecting random test sets this tends to
ensure that test and training sets both contain members of
the same series, which in turn means that the predictivity
of a model is greater than it might otherwise be.
Good and Hermsmeier proposed a protocol to evaluate
models that reduces this effect, by first organizing a drug
database into classes based on the drug ontology classes
defined by Schuffenhaur et al. [2]. They then learned
models from training sets that excluded a particular class
of drug and tested the predictivity on test sets from that
class. The authors focused on the ability of various meth-
ods to minimize type II errors (false negatives), that is the
prediction of drugs as non drugs.
After reproducing their work as far as we are able, we have
extended their study to also consider the effects on type I
errors (false positives), that is the prediction of a non drug
as a drug, which will be an important consideration when
one considers the practicality of these methods for select-
ing sets of samples for synthesis or purchase and screen-
ing.
In the reproduction of the original work, we largely con-
cur with the authors that descriptors that encode small
and more abstract features of molecules are the most effec-
tive at minimizing type II errors. However, minimizing
type I errors we found these types of descriptors not to be
so effective, and that it was descriptors that encompassed
much larger fragments produced the most predictive
models. In other words, the descriptors required for learn-
ing non-drugs are fundamentally different from those
required to learn drugs. We propose therefore that an
experiment can be tailored to meet the requirements of
precision vs recall by adjusting the environment size that
is encoded by the descriptors.
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